Study to Evaluate the Efficacy, Tolerability and Safety of Octanorm in Patients With Primary Immunodeficiency Diseases
Clinical trial NCT03988426 · COMPLETED
Trial details
- NCT number
- NCT03988426
- Sponsor
- Octapharma
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2017-03-07
- Primary completion
- 2018-01-26
- Enrollment
- 25
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.